Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity

NCT01652001 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
185
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universidad de Granada

Collaborators